News Conference News ACC 2018 ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins Shelley Wood March 10, 2018
News Daily News Bempedoic Acid Phase III Trial Meets Primary Endpoint for Cutting LDL Cholesterol Yael L. Maxwell March 08, 2018
News Daily News Beyond LDL Cholesterol: Lipoprotein Particles Linked With MI and Ischemic Stroke Michael O'Riordan February 07, 2018
News Daily News Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers Yael L. Maxwell January 24, 2018
News Daily News High Rate of Clinical Events at 6 Months for Ischemic CVD Patients Michael O'Riordan January 19, 2018
News Daily News Bariatric Surgery: Cardiometabolic Benefits Down, but Not Out, at 5 Years Michael O'Riordan January 18, 2018
News Daily News Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward Michael O'Riordan January 09, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors Michael O'Riordan December 12, 2017
News Daily News It’s Official: Evolocumab Gains Claim for CVD Event Reduction Michael O'Riordan December 04, 2017
News Daily News Genetic Study Hints at Role of Lipids in AAA Risk Michael O'Riordan November 30, 2017
Presentation Controversies and Advances 2017 Does IMPROVE-IT and FOURIER. Confirm or Refute the LDL Hypothesis? Presenter: Sanjay Kaul November 16, 2017
News Conference News AHA 2017 Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins Caitlin E. Cox November 14, 2017
News Conference News AHA 2017 Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017
News Conference News AHA 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017
Presentation TCT 2017 The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig October 30, 2017
News Daily News PCSK9 Inhibitors: More Data Show Disappointing Approval Rates of Prescriptions by Payers Yael L. Maxwell October 30, 2017
News Daily News Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients Michael O'Riordan October 26, 2017